Consultations on Pharmacogenomics / Biomarkers is one of the PMDA consultations. The purpose of this consultation is to provide general scientific advice for utilization of pharmacogenomics or biomarkers that are not specified in a certain product.
View this resource Bookmark this resource
Consultations on Pharmacogenomics / Biomarkers (As part of PMDA consultations)
Published by IRDiRC
Regulatory AffairsEarly Access SupportBiomarkerScientific AdviceMHLW or PMDA RegulatoryPharmacogenomicsPMDA